Abstract: The disclosure provides methods and compositions for modulating cellular aging comprising contacting a cell with an inhibitor of USP16. The disclosed methods may be used to improve the efficacy of cell-based therapies, including chimeric antigen receptor (CAR)-T cell therapies, engineered T cell receptor (TCR) therapies, natural killer (NK) cell therapies, hematopoietic stem cell-based therapies, and other adoptive cell therapies.
Type:
Application
Filed:
May 27, 2021
Publication date:
September 23, 2021
Applicant:
Dorian Therapeutics, Inc.
Inventors:
Benedetta NICOLIS DI ROBILANT, Maddalena ADORNO